Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Hamy, Anne-Sophie, Belin, Lisa, Bonsang-Kitzis, Hélène, Paquet, Caroline, Pierga, Jean-Yves, Lerebours, Florence, Cottu, Paul, Rouzier, Roman, Savignoni, Alexia, Lae, Marick, Reyal, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908674/
https://www.ncbi.nlm.nih.gov/pubmed/29462131
http://dx.doi.org/10.1038/bjc.2018.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908674/
https://www.ncbi.nlm.nih.gov/pubmed/29462131
http://dx.doi.org/10.1038/bjc.2018.4

Ejemplares similares